JP2015517464A5 - - Google Patents

Download PDF

Info

Publication number
JP2015517464A5
JP2015517464A5 JP2015510319A JP2015510319A JP2015517464A5 JP 2015517464 A5 JP2015517464 A5 JP 2015517464A5 JP 2015510319 A JP2015510319 A JP 2015510319A JP 2015510319 A JP2015510319 A JP 2015510319A JP 2015517464 A5 JP2015517464 A5 JP 2015517464A5
Authority
JP
Japan
Prior art keywords
days
recombinant
protein
falciparum
formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015510319A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015517464A (ja
JP6238967B2 (ja
Filing date
Publication date
Priority claimed from US13/844,261 external-priority patent/US9169304B2/en
Application filed filed Critical
Publication of JP2015517464A publication Critical patent/JP2015517464A/ja
Publication of JP2015517464A5 publication Critical patent/JP2015517464A5/ja
Application granted granted Critical
Publication of JP6238967B2 publication Critical patent/JP6238967B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015510319A 2012-05-01 2013-04-22 組み換え熱帯熱マラリア原虫スポロゾイト周囲タンパク質を精製するプロセス Active JP6238967B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261641105P 2012-05-01 2012-05-01
US61/641,105 2012-05-01
US13/844,261 2013-03-15
US13/844,261 US9169304B2 (en) 2012-05-01 2013-03-15 Process for purifying recombinant Plasmodium falciparum circumsporozoite protein
PCT/US2013/037656 WO2013165732A1 (en) 2012-05-01 2013-04-22 Process for purifying recombinant plasmodium falciparum circumsporozoite protein

Publications (3)

Publication Number Publication Date
JP2015517464A JP2015517464A (ja) 2015-06-22
JP2015517464A5 true JP2015517464A5 (cg-RX-API-DMAC7.html) 2016-06-16
JP6238967B2 JP6238967B2 (ja) 2017-11-29

Family

ID=49514758

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015510319A Active JP6238967B2 (ja) 2012-05-01 2013-04-22 組み換え熱帯熱マラリア原虫スポロゾイト周囲タンパク質を精製するプロセス

Country Status (16)

Country Link
US (2) US9169304B2 (cg-RX-API-DMAC7.html)
EP (1) EP2844666B1 (cg-RX-API-DMAC7.html)
JP (1) JP6238967B2 (cg-RX-API-DMAC7.html)
KR (1) KR102087461B1 (cg-RX-API-DMAC7.html)
CN (1) CN104379596B (cg-RX-API-DMAC7.html)
AR (1) AR090900A1 (cg-RX-API-DMAC7.html)
AU (1) AU2013256757B2 (cg-RX-API-DMAC7.html)
BR (1) BR112014027019B1 (cg-RX-API-DMAC7.html)
CA (1) CA2870198C (cg-RX-API-DMAC7.html)
MX (1) MX352093B (cg-RX-API-DMAC7.html)
MY (1) MY166380A (cg-RX-API-DMAC7.html)
NZ (1) NZ630121A (cg-RX-API-DMAC7.html)
SG (1) SG11201407108TA (cg-RX-API-DMAC7.html)
TW (1) TWI630213B (cg-RX-API-DMAC7.html)
WO (1) WO2013165732A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201407420B (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9169304B2 (en) 2012-05-01 2015-10-27 Pfenex Inc. Process for purifying recombinant Plasmodium falciparum circumsporozoite protein
WO2015105551A1 (en) * 2014-01-09 2015-07-16 Kentucky Bioprocessing, Inc. Method of purifying monoclonal antibodies
WO2015148943A1 (en) * 2014-03-28 2015-10-01 Conjugon, Inc. Preparation of small colony variants of therapeutic bacteria
ES2952405T3 (es) 2014-12-01 2023-10-31 Pfenex Inc Parejas de fusión para la producción de péptidos
CN109966319B (zh) * 2017-12-22 2022-11-22 四川好医生攀西药业有限责任公司 一种康复新液的原料及其制备方法和应用
CN108559721A (zh) * 2018-05-15 2018-09-21 北京师范大学 一种净化空气的复合微生物菌剂及其应用
EP4171630A1 (en) * 2020-06-29 2023-05-03 Path Pre-erythrocytic malaria vaccines

Family Cites Families (93)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2145092B (en) 1983-01-28 1988-04-07 Univ New York Protective peptide antigen
US4551433A (en) 1981-05-18 1985-11-05 Genentech, Inc. Microbial hybrid promoters
CH660375A5 (it) 1983-02-08 1987-04-15 Sclavo Spa Procedimento per la produzione di proteine correlate alla tossina difterica.
US4755465A (en) 1983-04-25 1988-07-05 Genentech, Inc. Secretion of correctly processed human growth hormone in E. coli and Pseudomonas
US5281532A (en) 1983-07-27 1994-01-25 Mycogen Corporation Pseudomas hosts transformed with bacillus endotoxin genes
US4830962A (en) 1984-02-09 1989-05-16 Cetus Corporation Recombinant diphtheria toxin fragments
ZA855232B (en) 1984-07-23 1986-02-26 Univ New York Protective peptide antigen corresponding to plasmodium falciparum circumsporozoite protein
US5178861A (en) 1984-09-12 1993-01-12 New York University Cross-reactive and protective epitopes of circumsporozoite proteins
NZ213303A (en) 1984-09-12 1988-09-29 Univ New York Plasmodium protein, dna sequence and vaccine
US4695455A (en) 1985-01-22 1987-09-22 Mycogen Corporation Cellular encapsulation of pesticides produced by expression of heterologous genes
US4695462A (en) 1985-06-28 1987-09-22 Mycogen Corporation Cellular encapsulation of biological pesticides
US4709017A (en) 1985-06-07 1987-11-24 President And Fellows Of Harvard College Modified toxic vaccines
GB8517071D0 (en) 1985-07-05 1985-08-14 Hoffmann La Roche Gram-positive expression control sequence
ATE118784T1 (de) 1985-07-12 1995-03-15 Univ New York Mit dem plasmodium-vivax-circumsporozoit-protein übereinstimmendes immunogenes peptidantigen.
CA1340373C (en) 1986-01-28 1999-02-02 Rino Rappuoli Cloning and sequencing of the dna fragment which codes for the five subunits of the pertussis toxin, a hybrid plasmid containing the dna fragment and micro-organisms transformed by the hybrid plasmid and capable of expressing all or some of the subunits of the pertussis toxin
EP0252588A3 (en) 1986-05-12 1989-07-12 Smithkline Beecham Corporation Process for the isolation and purification of p. falciparum cs protein expressed in recombinant e. coli, and its use as a vaccine
US4892827A (en) 1986-09-24 1990-01-09 The United States Of America As Represented By The Department Of Health And Human Services Recombinant pseudomonas exotoxins: construction of an active immunotoxin with low side effects
WO1988005817A1 (en) 1987-01-30 1988-08-11 Smith Kline - Rit S.A. Expression of the p. falciparum circumsporozoite protein by yeast
JP2918895B2 (ja) 1987-09-04 1999-07-12 アムジエン・インコーポレーテツド 組換え型ｄｎａ由来ボルデテラ毒素サブユニット類似体
US5792458A (en) 1987-10-05 1998-08-11 The United States Of America As Represented By The Department Of Health And Human Services Mutant diphtheria toxin conjugates
GB8727489D0 (en) 1987-11-24 1987-12-23 Connaught Lab Detoxification of pertussis toxin
US5128130A (en) 1988-01-22 1992-07-07 Mycogen Corporation Hybrid Bacillus thuringiensis gene, plasmid and transformed Pseudomonas fluorescens
AU625713B2 (en) 1988-02-19 1992-07-16 Microgenesys, Inc. Method for producing recombinant protein derived from the circumsporozoite gene of plasmodium falciparum
US5055294A (en) 1988-03-03 1991-10-08 Mycogen Corporation Chimeric bacillus thuringiensis crystal protein gene comprising hd-73 and berliner 1715 toxin genes, transformed and expressed in pseudomonas fluorescens
GB8812214D0 (en) 1988-05-24 1988-06-29 Hoffmann La Roche Use of peptide from circumsporozoite protein of p falciparum as universally recognized t-cell epitope
US5028425A (en) 1988-07-07 1991-07-02 The United States Of America As Represented By The Department Of Health And Human Services Synthetic vaccine against P. falciparum malaria
DE68927933T2 (de) * 1988-09-02 1997-08-14 Dyax Corp Herstellung und auswahl von rekombinantproteinen mit verschiedenen bindestellen
US6043057A (en) 1988-09-16 2000-03-28 Vitec Aktiebolag Recombinant systems for expression of the cholera B-sub-unit with the aid of foreign promoters and/or leader peptides
US6048728A (en) * 1988-09-23 2000-04-11 Chiron Corporation Cell culture medium for enhanced cell growth, culture longevity, and product expression
EP0409923A4 (en) 1988-12-21 1993-01-20 Smithkline Biologicals Expression of the i(plasmodium) circumsporozoite protein in insect cells
WO1990009444A1 (en) 1989-02-10 1990-08-23 Genesit Oy A method for producing pertussis toxin subunits
US7232671B2 (en) 1989-02-15 2007-06-19 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Pertussis toxin gene: cloning and expression of protective antigen
NZ233255A (en) 1989-04-11 1993-02-25 Chiron Corp Plasmodium cs protein analogues lacking one or more of the repeat epitopes, and containing at least one nonrepeat flanking epitope
DK0396964T3 (da) 1989-04-28 1995-10-30 Sclavo Spa Pertussistoxin-mutanter, Bordetella-stammer, der er i stand til at producere sådanne mutanter, samt deres anvendelse til udvikling af antipertussis-vacciner
GB8914122D0 (en) 1989-06-20 1989-08-09 Wellcome Found Polypeptide expression
US5169760A (en) 1989-07-27 1992-12-08 Mycogen Corporation Method, vectors, and host cells for the control of expression of heterologous genes from lac operated promoters
ATE93271T1 (de) 1989-11-28 1993-09-15 Wellcome Found Vakzine.
DK1279731T3 (da) 1991-03-01 2007-09-24 Dyax Corp Fremgangsmåde til udvikling af bindende miniproteiner
AU1762092A (en) 1991-04-01 1992-11-02 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Circumsporozoite protein of plasmodium reichenowi and vaccine for human malaria
US5935580A (en) 1992-04-21 1999-08-10 Institut Pasteur Recombinant mutants for inducing specific immune responses
CA2138997C (en) 1992-06-25 2003-06-03 Jean-Paul Prieels Vaccine composition containing adjuvants
EP0616034B1 (en) 1993-03-05 2004-10-20 Wyeth Holdings Corporation Plasmid for production of CRM protein and diphtheria toxin
EP0725653B2 (en) 1993-10-05 2008-04-02 UCB Pharma Limited Vaccine compositions
GB9406492D0 (en) 1994-03-31 1994-05-25 Isis Innovation Malaria peptides
US20040214157A1 (en) 1994-06-29 2004-10-28 Simon C. Burton Chromatographic resins and methods for using same
US5652348A (en) 1994-09-23 1997-07-29 Massey University Chromatographic resins and methods for using same
EP0785276A4 (en) 1994-09-29 2002-01-09 Ajinomoto Kk MODIFICATION OF A PEPTIDE AND A PROTEIN
US5932714A (en) 1995-02-23 1999-08-03 Connaught Laboratories Limited Expression of gene products from genetically manipulated strains of Bordetella
SE9600590D0 (sv) 1996-02-19 1996-02-19 Pharmacia Biotech Ab Sätt för kromatografisk separation av peptider och nukleinsyra samt ny högaffin jonbytesmatris
GB9616351D0 (en) 1996-08-02 1996-09-11 Smithkline Beecham Biolog Vaccine composition
WO1998012332A1 (en) 1996-09-17 1998-03-26 Chiron Corporation Compositions and methods for treating intracellular diseases
US7393630B2 (en) 1997-12-16 2008-07-01 Novartis Vaccines And Diagnostics, Inc. Use of microparticles combined with submicron oil-in-water emulsions
CA2359610A1 (en) 1999-02-18 2000-08-24 Rmf Dictagene S.A. Malaria vaccine
GB9904582D0 (en) 1999-02-26 1999-04-21 Nycomed Imaging As Process
US6942866B2 (en) 2000-08-16 2005-09-13 Apovia, Inc. Malaria immunogen and vaccine
AUPR011700A0 (en) 2000-09-14 2000-10-05 Austin Research Institute, The Composition comprising immunogenic virus sized particles (VSP)
US7781186B2 (en) 2000-09-25 2010-08-24 The United States Of America As Represented By The Secretary Of The Army Screening methods using normal human liver cell line
AU2001293074A1 (en) 2000-09-25 2002-04-08 Walter Reed Army Institute Of Research Human liver cell line
US7363166B2 (en) * 2001-03-30 2008-04-22 Council Of Scientific & Industrial Research Computational method for the identification of candidate proteins useful as anti-infectives
SE0104353D0 (sv) 2001-12-19 2001-12-19 Amersham Biosciences Ab Separation method
WO2004041857A2 (en) 2002-06-17 2004-05-21 Ballard Jimmy D Mutant of clostridium difficile toxin b and methods of use
US20040067880A1 (en) 2002-10-04 2004-04-08 Kuo Macus Tien Prodrug therapy of liver diseases using receptor-mediated delivery of malarial circumsporozoite protein as a carrier
US9453251B2 (en) 2002-10-08 2016-09-27 Pfenex Inc. Expression of mammalian proteins in Pseudomonas fluorescens
ES2594758T3 (es) 2002-10-23 2016-12-22 Glaxosmithkline Biologicals S.A. Procedimientos de vacunación contra la malaria
CA2507915C (en) 2002-12-17 2013-07-02 Crucell Holland B.V. Recombinant viral-based malaria vaccines
US7670631B2 (en) 2003-03-12 2010-03-02 ALFAMA—Investigação e Desenvolvimento de Produtos Farmacêuticos, Lda. Method for the prevention of malaria infection of humans by hepatocyte growth factor antagonists
US8399217B2 (en) 2003-03-14 2013-03-19 Brookhaven Science Associates, Llc High density growth of T7 expression strains with auto-induction option
JP5087741B2 (ja) 2003-11-19 2012-12-05 フェネックス インコーポレイテッド 改良タンパク質発現系
EP1687324B1 (en) 2003-11-21 2012-08-22 Pfenex, Inc. Improved expression systems with sec-system secretion
WO2005063805A1 (en) 2003-12-23 2005-07-14 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Antibodies against the amino terminus region of circumsporozoite protein prevent the onset of malaria infection
JP5602336B2 (ja) 2004-01-16 2014-10-08 フェネックス インコーポレイテッド シュードモナス・フルオレッセンスにおける哺乳動物タンパク質の発現
EP2412816B1 (en) 2004-07-26 2014-12-03 Pfenex Inc. Process for improved protein expression by strain engineering
AU2005277463A1 (en) 2004-08-20 2006-03-02 Kmt Hepatech, Inc. Malarial animal model having a chimeric human liver
GB0420634D0 (en) 2004-09-16 2004-10-20 Glaxosmithkline Biolog Sa Vaccines
AU2006214694B2 (en) 2005-01-18 2011-09-08 Walter Reed Army Institute Of Research A plasmodium vivax hybrid circumsporozoite protein and vaccine
EP1754717A1 (en) 2005-08-19 2007-02-21 Université de Lausanne Antigenic peptides and their use
BRPI0616602A2 (pt) 2005-09-30 2011-06-28 Seattle Biomedical Res Inst polipeptìdeo isolado, composição imunogênica, molécula de ácido nucleico isolada, e, uso de uma composição imunogênica
US7749519B2 (en) 2005-12-09 2010-07-06 Kim Lee Sim Unique DNA and polypeptide sequences based on the circumsporozoite protein of Plasmodium vivax
US20070292918A1 (en) 2006-05-30 2007-12-20 Stelman Steven J Codon optimization method
AU2008210538B2 (en) 2007-01-31 2013-06-06 Pelican Technology Holdings, Inc. Bacterial leader sequences for increased expression
EP2142651B1 (en) 2007-04-27 2013-05-22 Pfenex Inc. Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
US9580719B2 (en) 2007-04-27 2017-02-28 Pfenex, Inc. Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
CL2008002361A1 (es) 2007-08-13 2009-08-07 Glaxosmithkline Biologicals Sa Uso de un antigeno derivado de la proteina circumesporozoito (cs) de plasmodium falciparum que se expresa en la etapa preeritrocitica de la infeccion por malaria para tratar bebes contra la malaria.
WO2009114202A2 (en) 2008-03-14 2009-09-17 The United States Of America As Represented By The Secretary Of The Navy Vaccine and immunization method using plasmodium antigen 2
WO2010008764A1 (en) 2008-06-23 2010-01-21 Dow Global Technologies Inc. Pseudomonas fluorescens strains for production of extracellular recombinant protein
WO2010051360A1 (en) 2008-10-31 2010-05-06 Wyeth Llc Purification of acidic proteins using ceramic hydroxyapatite chromatography
US8063193B2 (en) 2009-03-27 2011-11-22 Abbott Laboratories Nucleotide and amino acid sequences encoding an exported protein 1 derived from Plasmodium vivax and uses thereof
ES2639398T3 (es) 2010-03-04 2017-10-26 Pfenex Inc. Método para producir proteína de interferón recombinante soluble sin desnaturalización
KR20130072201A (ko) 2010-03-30 2013-07-01 피페넥스 인크. 재조합 독소 단백질의 고수준 발현
WO2011139718A1 (en) 2010-05-03 2011-11-10 Genentech, Inc. Compositions and methods useful for reducing the viscosity of protein-containing formulations
DK2385107T3 (en) * 2010-05-03 2016-12-12 Pasteur Institut Lentiviral vector-based immunological compounds against malaria
WO2012154199A1 (en) 2010-10-18 2012-11-15 The Government Of The United States, As Represented By The Secretary Of The Army Soluble recombinant plasmodium falciparum circumsporozoite protein
US9169304B2 (en) 2012-05-01 2015-10-27 Pfenex Inc. Process for purifying recombinant Plasmodium falciparum circumsporozoite protein

Similar Documents

Publication Publication Date Title
JP2015517464A5 (cg-RX-API-DMAC7.html)
CN105408348B (zh) 稳定化的可溶性融合前rsv f多肽
AR108442A1 (es) Proteínas de fusión gdf15 y usos de estas
RS58436B1 (sr) Stabilizovani rastvorljivi pre-fuzioni rsv f polipeptidi
JP2016520075A5 (cg-RX-API-DMAC7.html)
US20190077828A1 (en) High ph protein refolding methods
JP2014527072A5 (cg-RX-API-DMAC7.html)
US20190169229A1 (en) Tangential flow filtration based protein refolding methods
CN106399321A (zh) 一种制备融合表达重组鸡α干扰素的生产工艺
KR102087461B1 (ko) 재조합 플라스모디움 팔시파룸 포자소체 단백질의 정제 방법
JP2015508664A (ja) カラムでの酵素的切断
JP2018529654A (ja) 抗体のフラグメントの改善されたリフォールディング方法
CN104926924A (zh) 一种利用手性锍盐侧链稳定多肽α-螺旋二级结构的方法
Gautam et al. Non-chromatographic strategies for protein refolding
Voráčková et al. Purification of proteins containing zinc finger domains using immobilized metal ion affinity chromatography
CN103570836B (zh) 一种重组猪干扰素β1-Fc融合蛋白及其编码基因和表达方法
CN106068127B (zh) 蛋白质的硫醚缀合方法
CN103193887B (zh) 一种重组猪白细胞介素2-Fc融合蛋白及其编码基因和表达方法
CN104163850B (zh) 一种小分子抗体亲和肽及其应用
WO2013065343A1 (ja) 非ペプチドヒンジ部含有フレキシブル抗体様分子
JP2019518713A5 (cg-RX-API-DMAC7.html)
JP7703541B2 (ja) 血清アルブミン結合性フィブロネクチンｉｉｉ型ドメインおよびその使用
CN104610443A (zh) 一种高稳定性重组降钙素原、制备方法及用途
JP3930051B2 (ja) 正しく折畳まれた生物学的に活性の組換えタンパク質の製造方法
CN104628851B (zh) 一种抗狂犬病毒的基因工程抗体、其制备方法和应用